The Cochrane Library: Cochrane Database of Systematic Reviews

DOI: 10.1002/14651858

Reviews/Protocols listed by Cochrane Review Group

  1. Cochrane Acute Respiratory Infections Group
  2. Cochrane Airways Group
  3. Cochrane Anaesthesia, Critical and Emergency Care Group
  4. Cochrane Back and Neck Group
  5. Cochrane Bone, Joint and Muscle Trauma Group
  6. Cochrane Breast Cancer Group
    1. About this group
    2. Reviews
      1. Addition of drug/s to a chemotherapy regimen for metastatic breast cancerReview
      2. Antibiotics / anti-inflammatories for reducing acute inflammatory episodes in lymphoedema of the limbsReviewWithdrawn
      3. Antitumour antibiotic containing regimens for metastatic breast cancerReview
      4. Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal womenReview
      5. Axillary treatment for operable primary breast cancerReviewNew
      6. Benzo-pyrones for reducing and controlling lymphoedema of the limbsReview
      7. Bisphosphonates and other bone agents for breast cancerReview
      8. Cancer genetic risk assessment for individuals at risk of familial breast cancerReview
      9. Chemotherapy alone versus endocrine therapy alone for metastatic breast cancerReview
      10. Chinese medicinal herbs to treat the side-effects of chemotherapy in breast cancer patientsReview
      11. Combination versus sequential single agent chemotherapy for metastatic breast cancerReview
      12. Conservative interventions for preventing clinically detectable upper-limb lymphoedema in patients who are at risk of developing lymphoedema after breast cancer therapyReview
      13. Different types of implants for reconstructive breast surgeryReview
      14. Exercise for women receiving adjuvant therapy for breast cancerReview
      15. Exercise interventions for upper-limb dysfunction due to breast cancer treatmentReview
      16. Fibrin glue instillation under skin flaps to prevent seroma-related morbidity following breast and axillary surgeryReview
      17. Follow-up strategies for women treated for early breast cancerReview
      18. Fraction size in radiation therapy for breast conservation in early breast cancerReview
      19. Fulvestrant for hormone-sensitive metastatic breast cancerReviewNew
      20. High-dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with early poor prognosis breast cancerReview
      21. High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with metastatic breast cancerReview
      22. Immediate versus delayed reconstruction following surgery for breast cancerReview
      23. Interventions for relieving the pain and discomfort of screening mammographyReview
      24. LHRH agonists for adjuvant therapy of early breast cancer in premenopausal womenReview
      25. Localization techniques for guided surgical excision of non-palpable breast lesionsReview
      26. Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in women at average riskReview
      27. Manual lymphatic drainage for lymphedema following breast cancer treatmentReview
      28. Methods of communicating a primary diagnosis of breast cancer to patientsReview
      29. Multi-agent chemotherapy for early breast cancerReviewWithdrawn
      30. Multidisciplinary rehabilitation for follow-up of women treated for breast cancerReview
      31. Nipple- and areola-sparing mastectomy for the treatment of breast cancerReview
      32. Non-hormonal interventions for hot flushes in women with a history of breast cancerReview
      33. Ovarian ablation for early breast cancerReviewWithdrawn
      34. Partial breast irradiation for early breast cancerReview
      35. Physical therapies for reducing and controlling lymphoedema of the limbsReview
      36. Platinum containing regimens for metastatic breast cancerReview
      37. Post-operative radiotherapy for ductal carcinoma in situ of the breastReview
      38. Postoperative tamoxifen for ductal carcinoma in situReview
      39. Preoperative chemotherapy for women with operable breast cancerReview
      40. Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patientsReview
      41. Prophylactic mastectomy for the prevention of breast cancerReview
      42. Psychological interventions for women with metastatic breast cancerReview
      43. Psychological interventions for women with non-metastatic breast cancerReview
      44. Radiotherapy for early breast cancerReviewWithdrawn
      45. Regular self-examination or clinical examination for early detection of breast cancerReview
      46. Screening for breast cancer with mammographyReview
      47. Sequencing of chemotherapy and radiotherapy for early breast cancerReview
      48. Single agent versus combination chemotherapy for metastatic breast cancerReview
      49. Specialist breast care nurses for supportive care of women with breast cancerReview
      50. Strategies for increasing the participation of women in community breast cancer screeningReview
      51. Surgery versus primary endocrine therapy for operable primary breast cancer in elderly women (70 years plus)Review
      52. Systemic therapy for treating locoregional recurrence in women with breast cancerReview
      53. Tamoxifen for early breast cancerReviewWithdrawn
      54. Taxane-containing regimens for metastatic breast cancerReview
      55. Taxanes for adjuvant treatment of early breast cancerReview
      56. Timing of breast surgery in premenopausal breast cancer patientsReview
      57. Toremifene versus tamoxifen for advanced breast cancerReview
      58. Trastuzumab containing regimens for early breast cancerReview
      59. Trastuzumab-containing regimens for metastatic breast cancerReview
      60. Vascular-endothelial-growth-factor (VEGF) targeting therapies for endocrine refractory or resistant metastatic breast cancerReview
      61. Wound drainage after axillary dissection for carcinoma of the breastReview
      62. Yoga for improving health-related quality of life, mental health and cancer-related symptoms in women diagnosed with breast cancerReviewNew
    3. Protocols
      1. Acellular dermal matrices for breast reconstruction surgeryProtocol
      2. Acupuncture for treatment-related side effects in women with breast cancerProtocol
      3. Aromatase Inhibitors for the adjuvant treatment of breast cancer in postmenopausal womenProtocol
      4. Autologous fat grafting for breast reconstructionProtocol
      5. Bisphosphonates for prevention of bone loss in women with early breast cancerProtocol
      6. Body weight management in overweight and obese breast cancer survivorsProtocol
      7. Breast surgery for metastatic breast cancerProtocol
      8. Capecitabine for ER-positive versus ER-negative breast cancerProtocol
      9. Duration of chemotherapy for metastatic breast cancerProtocol
      10. Home-based multidimensional survivorship programmes for breast cancer survivorsProtocol
      11. Intensity-modulated versus conventional radiotherapy for breast cancerProtocol
      12. Interventions for raising breast cancer awareness in womenProtocol
      13. Inverted T versus vertical scar incision technique for women undergoing breast reduction surgeryProtocol
      14. Lapatinib for advanced breast cancer overexpressing HER2ProtocolWithdrawn
      15. Mindfulness-based stress reduction for women diagnosed with breast cancerProtocol
      16. Omission of whole breast irradiation for postmenopausal women with early breast cancerProtocolNew
      17. Online support groups for women with breast cancerProtocol
      18. Physical activity for women with breast cancer after adjuvant therapyProtocol
      19. Poly(ADP-Ribose) Polymerase (PARP) Inhibitors for locally advanced or metastatic breast cancerProtocol
      20. Post-mastectomy radiotherapy for breast cancer patients with 1 to 3 positive lymph nodesProtocolWithdrawn
      21. Preservation of the intercostobrachial nerve during axillary node clearance for breast cancerProtocol
      22. Risk-reducing medication for primary breast cancer: a network meta-analysisProtocol
      23. Skin-sparing mastectomy for the treatment of breast cancerProtocol
      24. Surgical interventions for the prevention or treatment of lymphoedema after breast cancer treatmentProtocol
      25. Tumour bed boost radiotherapy for women after breast conserving surgeryProtocol
  7. Cochrane Childhood Cancer Group
  8. Cochrane Colorectal Cancer Group
  9. Cochrane Common Mental Disorders Group
  10. Cochrane Consumers and Communication Group
  11. Cochrane Cystic Fibrosis and Genetic Disorders Group
  12. Cochrane Dementia and Cognitive Improvement Group
  13. Cochrane Developmental, Psychosocial and Learning Problems Group
  14. Cochrane Drugs and Alcohol Group
  15. Cochrane Effective Practice and Organisation of Care Group
  16. Cochrane ENT Group
  17. Cochrane Epilepsy Group
  18. Cochrane Eyes and Vision Group
  19. Cochrane Fertility Regulation Group
  20. Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group
  21. Cochrane Gynaecology and Fertility Group
  22. Cochrane Haematological Malignancies Group
  23. Cochrane Heart Group
  24. Cochrane Hepato-Biliary Group
  25. Cochrane HIV/AIDS Group
  26. Cochrane Hypertension Group
  27. Cochrane IBD Group
  28. Cochrane Incontinence Group
  29. Cochrane Infectious Diseases Group
  30. Cochrane Injuries Group
  31. Cochrane Kidney and Transplant Group
  32. Cochrane Lung Cancer Group
  33. Cochrane Metabolic and Endocrine Disorders Group
  34. Cochrane Methodology Review Group
  35. Cochrane Movement Disorders Group
  36. Cochrane Multiple Sclerosis and Rare Diseases of the CNS Group
  37. Cochrane Musculoskeletal Group
  38. Cochrane Neonatal Group
  39. Cochrane Neuromuscular Group
  40. Cochrane Oral Health Group
  41. Cochrane Pain, Palliative and Supportive Care Group
  42. Cochrane Pregnancy and Childbirth Group
  43. Cochrane Public Health Group
  44. Cochrane Schizophrenia Group
  45. Cochrane Skin Group
  46. Cochrane STI Group
  47. Cochrane Stroke Group
  48. Cochrane Tobacco Addiction Group
  49. Cochrane Upper GI and Pancreatic Diseases Group
  50. Cochrane Urology Group
  51. Cochrane Vascular Group
  52. Cochrane Work Group
  53. Cochrane Wounds Group